华法林在心房颤动抗凝治疗中的应用

被引：34

作者：

何华

马长生

机构：

[1] 首都医科大学附属北京安贞医院心内科

来源：

国际心血管病杂志 | 2008年 / 01期

关键词：

华法林; 心房颤动; 抗凝治疗;

D O I：

暂无

中图分类号：

R541.75 [];

学科分类号：

摘要：

心房颤动(AF)是最常见的持续性心律失常,其主要可能致命的危险就是血栓形成。华法林抗凝治疗可显著减少2/3卒中风险,对瓣膜病和非瓣膜病AF均有效,但存在监测较麻烦、治疗窗窄、有潜在出血危险等不利之处。本文比较了华法林临床应用与其他口服凝血酶抑制剂和Xa因子拮抗剂及抗血小板药物治疗的现状。

引用

收藏

页码：16 / 19

页数：4

相关论文

共 5 条

[1] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
Connolly, S.
Pogue, J.
Hart, R.
Pfeffer, M.
Hohnloser, S.
Chrolavicius, S.
Yusuf, S.
[J]. LANCET, 2006, 367 (9526) : 1903 - 1912
[2] Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation - The role of homocysteine
Poli, D
Antonucci, E
Cecchi, E
Marcucci, R
Liotta, AA
Cellai, AP
Lenti, M
Gensini, GF
Abbate, R
Prisco, D
[J]. STROKE, 2005, 36 (10) : 2159 - 2163
[3] Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation - The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
Fang, MC
Singer, DE
Chang, YC
Hylek, EM
Henault, LE
Jensvold, NG
Go, AS
[J]. CIRCULATION, 2005, 112 (12) : 1687 - 1691
[4] Antithrombotic therapy for stroke prevention in atrial fibrillation
Go, AS
Fang, MC
Singer, DE
[J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 48 (02) : 108 - 124
[5] Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
Albers, GW
Diener, HC
Grind, M
Halperin, JL
Horrow, J
Olsson, SB
Petersen, P
Vahanian, A
Frison, L
Nevinson, M
Partridge, S
[J]. LANCET, 2003, 362 (9397) : 1691 - 1698